Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.
The acquisition expands Globus Medical’s reach in the musculoskeletal market and the opportunity to add to its product portfolio.
The deal was first announced in February, and Nevro was valued at $250 million. Nevro employs HFX spinal cord stimulation, which is used in its Senza SCS system. The company also offers minimally invasive treatments for chronic sacroiliac joint pain.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.